Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)

Clinical trial NCT05735158 · UNKNOWN

Trial details

NCT number: NCT05735158
Sponsor: Krystal Biotech, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Autosomal Recessive Ichthyosis

Start date: 2023-03-01
Primary completion: 2024-03-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.